Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.

Dementia l: Introduction

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...

Psychoneuroimmunology: Diabetes and Cancer

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Cognitive Development During Adulthood

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Vascular Contribution to Dementia. World Stroke Organisation Scientific Statement.

International journal of stroke : official journal of the International Stroke Society·2026

Same author

Dementia in type 2 diabetes: risk factors, disease processes and opportunities for prevention across the lifespan.

Diabetologia·2026

Same author

Impact of risk factor burden and vascular bed involvement on dementia risk in individuals with established cardiovascular disease.

American journal of preventive cardiology·2026

Same author

Prediabetes as a critical stage for risk of dementia and stroke: evidence from the UK Biobank and Mendelian Randomization.

European journal of preventive cardiology·2026

Same author

Data-driven subtypes of type 2 diabetes and risk of dementia, stroke, and brain structural changes in the UK Biobank.

Diabetes research and clinical practice·2026

Same author

ADAMTS13 and von Willebrand Factor in relation to vascular cognitive impairment and cerebral small vessel disease: the heart-brain connection study.

Journal of thrombosis and haemostasis : JTH·2026

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Caffeine, diabetes, cognition, and dementia.

Geert Jan Biessels¹

¹Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Center, Utrecht, The Netherlands. g.j.biessels@umcutrecht.nl

Journal of Alzheimer'S Disease : JAD

|February 26, 2010

Summary

Caffeine may lower the risk of type 2 diabetes and dementia. However, more research is needed to confirm if coffee consumption is safe for people with diabetes or at risk.

Area of Science:

Neuroscience
Endocrinology
Epidemiology

Background:

Diabetes mellitus increases the risk of cognitive dysfunction.
Type 2 diabetes (T2DM) significantly impacts cognitive health.
Understanding modifiable factors like caffeine intake is crucial for managing diabetes-related cognitive decline.

Purpose of the Study:

To review the relationship between caffeine intake, diabetes, cognition, and dementia.
To focus on the specific context of type 2 diabetes (T2DM).
To explore caffeine's potential role in modulating cognitive decline risk in diabetic individuals.

Main Methods:

Review of epidemiological studies on caffeine/coffee intake and T2DM risk.
Analysis of the impact of T2DM on cognitive function.

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Related Experiment Videos

Last Updated: Jun 15, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Exploration of caffeine's potential neuroprotective effects in diabetes.

Main Results:

Epidemiological data suggest coffee/caffeine consumption is linked to a reduced risk of T2DM.
A possible association between caffeine intake and decreased dementia risk was observed.
Current evidence does not confirm a causal relationship for these associations.

Conclusions:

While observational studies show potential benefits, causality remains unproven.
Recommendations for caffeine consumption in T2DM or pre-diabetic individuals are currently difficult to establish.
Caffeine possesses properties warranting further investigation for its role in diabetes and cognitive health.